Episodes

  • J.P. Morgan Healthcare 2026 and Beyond: Regulation, Technology and the Future of Health Equity

    J.P. Morgan Healthcare 2026 and Beyond: Regulation, Technology and the Future of Health Equity
    Mar 5 2026
    Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Adam Herbst, a partner in Sheppard's Healthcare industry team, to explore key insights from the 2026 J.P. Morgan Healthcare Conference and discuss both the pitfalls and opportunities the One Big Beautiful Bill (OBBBA) presents for the healthcare sector. What we discuss in this episode: What does the increased use of technology in healthcare mean for the aging population? What key considerations should healthcare leaders keep in mind as they adapt to OBBBA when caring for aging populations? Practical challenges providers will encounter as they seek to deploy technology solutions to address additional OBBBA restrictions. How might OBBBA change the way health systems negotiate partnerships or structure payer contracts? What are some positive outcomes that could arise with these changes? Which anticipated changes in healthcare delivery excite you most about the future of health equity? About Adam Herbst Adam Herbst is a nationally regarded authority at the intersection of healthcare law, policy and delivery, with nearly three decades of experience spanning government, health systems, nonprofits and the private sector. He advises on the full range of corporate and transactional healthcare matters including mergers, acquisitions, joint ventures and financings involving hospitals, long-term care facilities, managed care organizations and private equity funds. He is also widely recognized for his mastery of Medicaid law, financing and policy. His Medicaid work includes 1115 waivers, state-directed payments, managed care contracting, HCBS waiver design, PACE program expansion and long-term care reimbursement across multiple states. Adam regularly structures governance arrangements, negotiates complex management and administrative services agreements and guides providers and investors through multi-state regulatory approvals and compliance regimes. Clients value Adam's ability to combine inside knowledge of government with sophisticated deal experience and a genuine understanding of mission-driven care. Whether guiding a multi-state transaction, structuring a PACE or HCBS program, advising on Medicaid waivers or supporting aging and disability service organizations, he brings a holistic approach that integrates law, policy, operations and strategy, helping clients build sustainable, compliant growth models while advancing care for vulnerable populations. Before joining Sheppard, Adam served as Deputy Commissioner of the New York State Department of Health and as a special advisor to two governors, where he led major initiatives in Medicaid transformation, long-term care reform, and managed care modernization, and chaired New York's Master Plan for Aging. During the COVID-19 pandemic, he played a critical leadership role in the state's emergency response—coordinating with federal partners, standing up COVID-only nursing facilities, managing hospital surge capacity and supporting one of the largest vaccine distribution efforts in the country. His career has also included running a children's hospital, leading a major community health center and advising faith-based organizations and disability service agencies through periods of growth, transformation and financial stress. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health & Innovation team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, mobile health applications, clinical decision support technologies, artificial intelligence, data use, wearable devices, remote patient monitoring, and other medical devices, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Michael founded a software-as-a-service company before entering private practice and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It...
    Show More Show Less
    13 mins
  • J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure

    J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure
    Feb 20 2026
    Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Eric Newsom, partner and Transactions lead of Sheppard's national Healthcare industry team, to discuss key takeaways from the 2026 J.P. Morgan Healthcare Conference and explore what growing AI adoption, shifting reimbursement models and evolving macroeconomics mean for M&A and strategic partnerships. What we discuss in this episode: How the conference addressed the growing focus on AI-powered healthcare platforms. The key factors driving adoption of AI technologies across the healthcare industry. How providers and payers are adjusting their M&A and joint‑venture strategies amid shifting reimbursement models and evolving macroeconomic pressures. The top three priorities for healthcare leaders when advancing AI adoption and structuring strategic partnerships. Topics not covered at the conference that Eric would have liked to learn more about. About Eric Newsom Eric Newsom is a partner in the Corporate practice group in Sheppard's San Francisco office and serves as Transactions Lead of the firm's national Healthcare industry team. Eric's nationwide practice focuses on mergers and acquisitions, strategic joint ventures, corporate reorganizations, private equity and venture capital transactions, and corporate governance and compliance matters. Eric has represented buyers, sellers, investors, and intermediaries in numerous business combinations, buyouts, and investment transactions, with particular emphasis on the healthcare industry. In his healthcare and health technology practice, Eric advises on mergers, acquisitions, affiliations, comprehensive corporate reorganizations, multi-channel joint ventures, and private equity investment and disposition transactions. His experience spans for-profit, nonprofit, and government-owned hospital and provider systems; academic medical centers; health plans; physician groups; ambulatory and specialty service providers; and startup and growth-stage companies in the healthcare information technology sector. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health & Innovation team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, mobile health applications, clinical decision support technologies, artificial intelligence, data use, wearable devices, remote patient monitoring, and other medical devices, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Michael founded a software-as-a-service company before entering private practice and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Eric Newsom Michael Orlando Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    Show More Show Less
    19 mins
  • J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A

    J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
    Feb 9 2026
    Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Amanda Zablocki, co-leader of Sheppard's Healthcare industry team, to explore key insights from the 2026 J.P. Morgan Healthcare Conference and discuss how digital innovation is transforming the healthcare M&A landscape What We Discuss in This Episode: How did buzzwords like AI and innovation shape conversations at this year's J.P. Morgan Healthcare Conference? What role does technology play in healthcare transactions? How is AI driving the next wave of consolidation among hospitals, health systems and health plans? What are the challenges and opportunities in integrating technology platforms during mergers and acquisitions? How does technology leadership influence whether an organization becomes a buyer, partner or target, and why is it critical to involve technology leaders early in the deal-making process? What is the impact of data assets, analytics platforms and AI-driven tools on healthcare transactions? How can organizations balance the cost of technology with their mission to serve patients and communities? What legal and regulatory considerations should healthcare organizations prioritize when adopting new technologies? About Amanda Zablocki Amanda Zablocki is a partner in the Corporate practice group in Sheppard's New York office and co-leader of the firm's Healthcare Industry team. A trusted legal and strategic advisor to healthcare organizations nationwide, she helps them to achieve their mission and goals while navigating a dynamic regulatory landscape. Large-scale, strategic transactions—mergers and acquisitions, joint ventures and strategic partnerships, and corporate reorganizations—are at the center of Amanda's practice. With extensive industry knowledge, a deep understanding of the key drivers and levers for success, and broad experience navigating the complex healthcare regulatory landscape, she helps clients close high-impact deals that transform healthcare. Amanda's clients include health plans and health insurers, hospital systems, academic medical centers, digital health and healthcare technology companies, pharmaceutical and life sciences companies, rare disease organizations, physician practices, management services organizations, value-based care organizations, and 501(c)(3) organizations. Having begun her career in commercial litigation, she brings a litigator's eye to managing risk in connection with disputes and advocating her clients' positions. Amanda co-founded Sheppard's Women in Healthcare Leadership Collaborative, an exclusive initiative that provides support to women professionals in the healthcare and life sciences industries. She is also co-founder and a board member of Hyper IgM Foundation, an organization committed to improving the treatment, quality of life and long-term outlook for children and adults living with Hyper IgM. About Michael Orlando Michael Orlando is a partner in Sheppard's San Diego (Del Mar) office. He is team leader of the firm's Technology Transactions team, a member of the Life Sciences, Healthcare and Artificial Intelligence teams, and co-leader of the firm's Digital Health team. Michael has more than 20 years of experience advising health technology companies, insurers, healthcare systems and providers, academic medical centers and research institutions, medical device manufacturers, and pharmaceutical and wellness companies on intellectual property and business transactions in key strategic areas, including EHR systems procurement and integration, telehealth, wearable devices, remote patient monitoring, mobile health applications, clinical decision support technologies, artificial intelligence, data use, research and collaborations, patent licenses, software licenses, joint ventures, mergers and acquisitions, revenue cycle management, and other outsourcing transactions. Before entering private practice, Michael founded a software-as-a-service company and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Amanda Zablocki Michael Orlando Resources Women in Leadership Healthcare Collaborative (WHLC) Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    Show More Show Less
    18 mins
  • From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs

    From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs
    Dec 4 2025
    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Michael Orlando welcomes Amy Dilcher and Chi Huynh, co-chairs of Sheppard Mullin's Women in Healthcare Leadership Collaborative (WHLC), to discuss key takeaways from the 2025 WHLC Leadership Summit. What We Discussed in this Episode: What is WHLC, and what is its mission? What is the purpose of the annual leadership summit? What was the theme for 2025? What topics were discussed during this year's summit panels? What were the key takeaways regarding healthcare transactions, AI, reimbursement and regulatory changes, and telehealth? Looking ahead to 2026, what's on WHLC's agenda? How can the annual summit help advance women in healthcare leadership? What do you see as the key drivers that help support women in leadership? How does the WHLC summit encourage collaboration? What is Legal Bridge Services, and what drove its creation? About Amy Dilcher Amy Dilcher is a partner in the Corporate Practice Group in Sheppard Mullin's Washington, D.C. office and Co-Chair of WHLC. With more than 25 years in the healthcare industry and a prior career as an oncology nurse, Amy's dual understanding of the clinical and legal aspects of healthcare enables her to deliver practical, tailored solutions that balance business goals with regulatory compliance. Amy advises hospitals, health systems, and private equity–backed organizations on strategic affiliations, hospital and physician transactions, regulatory compliance, and operational risk. Her background as Chief Legal Officer and General Counsel enables her to offer practical guidance that aligns legal strategy with business and clinical priorities. Her practice includes structuring and negotiating complex healthcare transactions, developing compliance programs, and supporting post-transaction integration. She also provides ongoing counsel to leadership teams navigating regulatory and operational challenges. Amy is certified as a Yellow Belt in Legal Process Improvement and Project Management through Legal Lean Sigma, and she assists clients in strengthening legal operations, improving workflow efficiency, and enhancing organizational performance. About Chi Huynh Chi Huynh is a partner in the Corporate Practice Group in Sheppard Mullin's Century City office and Co-Chair of WHLC. Her practice focuses on healthcare transactions, compliance, mergers and acquisitions, and corporate governance. Chi represents physician groups, independent physician associations, hospitals and affiliated foundations, nonprofit health organizations, pharmacies, and other healthcare entities in mergers and acquisitions, operational matters, contracting, and general corporate counsel work. She also handles healthcare regulatory issues involving information privacy, the corporate practice of medicine, anti-kickback rules, and Stark Law considerations. She also advises public and private companies, private equity firms, and strategic investors on mergers and acquisitions, joint ventures, investment structures, and corporate governance. Her work spans a range of industries, including semiconductor, food and beverage, specialty manufacturing, entertainment, energy, and renewable energy. Before joining Sheppard Mullin, Chi served as Associate General Counsel at IPC Healthcare, Inc., where she led a team responsible for negotiating, documenting, and closing more than 35 acquisitions across multiple states. About Michael Orlando Michael Orlando is a corporate and intellectual property transactions attorney in Sheppard Mullin's San Diego (Del Mar) office, where he leads the firm's Technology Transactions Team and is a member of the Life Sciences and Healthcare teams. Michael advises technology companies on the development, commercialization, and procurement of their products. His expertise covers a broad spectrum of transactions, including licensing, outsourcing, joint ventures, mergers and acquisitions, collaborations, and strategic partnerships. By integrating corporate and intellectual property law, Michael structures deals that align his clients' legal, technical, and business objectives. His practice serves a diverse range of industries—from biotechnology and digital health to aerospace and automotive technologies, with a particular focus on electric, autonomous, and connected vehicle systems. He represents a wide array of clients, from early-stage startups to Fortune 500 companies. Before entering private practice, Michael founded a software-as-a-service company and completed an in-house secondment at a publicly traded biotechnology company, an experience that informs his practical and business-focused approach to client engagements. Contact Info Amy Dilcher Chi Huynh Michael Orlando Resources Women in Leadership Healthcare Collaborative (WHLC) Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new ...
    Show More Show Less
    14 mins
  • AI in Clinical Research: Opportunities, Risks, and the Road Ahead with Bill Kish and Dr. Brad Pruitt of Kenosha AI

    AI in Clinical Research: Opportunities, Risks, and the Road Ahead with Bill Kish and Dr. Brad Pruitt of Kenosha AI
    Jul 24 2025
    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Sara Shanti welcomes Bill Kish and Dr. Brad Pruitt of Kenosha AI to explore how artificial intelligence can enhance efficiency and compliance in healthcare research. What is Kenosha AI, and what is its potential role in transforming healthcare and research operations? Who are the end users of Kenosha AI's products, and how are these products positioned to deliver immediate, tangible impacts for their missions? Looking ahead, how might this momentum build, and what direction could clinical research take with the advancements enabled by AI? What are the risks and concerns associated with hallucinations, synthetic data, and the trustworthiness of AI deliverables? Where can healthcare stakeholders feel comfortable jumping in on AI, and where does it make sense to wait for further development? What tasks should clinicians and researchers prioritize when exploring the potential applications of AI? About Bill Kish Bill Kish is the CEO and Co-Founder of Kenosha AI, bringing over 30 years of dynamic experience as a technologist, entrepreneur, and leader across five successful startups. His expertise has led burgeoning companies to flourish into multi-billion-dollar enterprises, solidifying his position as an industry innovator. A graduate with honors in Computer Engineering from Carnegie Mellon University, Bill's career has been defined by groundbreaking advancements in AI and machine learning applications. He co-founded Ruckus Wireless, serving as CTO and Board Director, where his contributions shaped the company into a $400M/year business and a leader in the wireless technology industry, culminating in a $1.5 billion acquisition by Brocade. At Cogniac Corporation, Bill enabled industries to leverage AI-powered visual inspection, serving as the CEO and CTO to drive operational innovation. He also founded Jiggy AI, a boutique AI consulting firm specializing in large language model applications. Additionally, as the organizer of the Silicon Valley Machine Learning Meetup, Bill has fostered a thriving global community of over 10,000 members passionate about machine learning. About Dr. Brad Pruitt Dr. Brad Pruitt is the President and Co-Founder of Kenosha AI. With over 25 years of experience in clinical research and healthcare, including 13 years in the Contract Research Organization (CRO) industry, he specializes in revolutionizing clinical trials through advanced AI-powered tools like copilots and GPTs. Dr. Pruitt is a seasoned executive and entrepreneur with a proven track record of leading ventures to success. He has held executive roles at top-tier CROs, served as the Founding CEO of an acquired startup, and contributed to three successful acquisitions in the past eight years. His prior leadership roles include Chief Medical Officer at Alethium Health Systems, where he developed go-to-market strategies for clinical trial innovation, and Senior Vice President of Medical Affairs at Safe Health, where he drove business expansion into connected diagnostics. In addition to his role with Kenosha AI, Dr. Pruitt is a Principal at Prucor and serves as a mentor and advisor for healthcare and clinical trial technology companies participating in the EvoNexus incubator program. Dr. Pruitt earned his MD from Michigan State University College of Human Medicine and his MBA from UC San Diego's Rady School of Management. His academic foundation, combined with his professional achievements, positions him as a visionary leader at the intersection of technology, healthcare, and clinical research. About Sara Shanti A partner in the Corporate Practice Group in Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti's practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care. Contact Information Bill Kish Dr. Brad Pruitt Sara Shanti Additional Resources Kenosha AI - Kenosha AI is currently offering a free trial of its RegChatTM, which is an AI-powered Clinical Regulatory Guidance Assistant that provides a simple chat interface for answering questions about global regulatory guidance using AI and official regulatory ...
    Show More Show Less
    14 mins
  • Navigating AI: Governance and Innovation at UCSD Health with Ron Skillens of UCSD Health

    Navigating AI: Governance and Innovation at UCSD Health with Ron Skillens of UCSD Health
    Apr 21 2025

    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Ron Skillens, Chief Compliance and Privacy Officer at UC San Diego Health, joins host and Sheppard Mullin partner Michael Orlando to discuss the transformative potential of AI in healthcare and the importance of balancing innovation with compliance.

    What We Discussed in This Episode:

    • How could AI transform patient care and hospital operations in the next five years?

    • With health data being as sensitive and valuable as it is, why is an AI governance structure crucial for the creative and compliant use of AI?

    • How can AI usage be effectively managed and coordinated between stakeholders to strike the right balance of innovation and risk?

    • What have been some of the biggest challenges and lessons learned when establishing an AI governance structure?

    • In what ways does patient interest shape the evaluation of AI applications in healthcare?

    • What is the best way to keep staff and stakeholders updated on the latest AI advancements, emerging trends and best practices?

    About Ron Skillens

    Ron Skillens is the chief compliance and privacy officer for UC San Diego Health. He is responsible for the mitigation of compliance and regulatory risks, pursuing leading practices and ensuring that all Health compliance and privacy activities are coordinated with the appropriate leaders.

    In addition, Mr. Skillens provides health care research compliance support for UC San Diego Health Sciences and is responsible for administering the health system's policy and procedure process. He has more than 30 years of compliance, audit and risk management experience working with diverse senior leadership, physicians and boards, bringing to this position a demonstrated commitment to compliance and collaboration.

    About Michael Orlando

    Michael Orlando is a corporate and intellectual property transactions partner in Sheppard Mullin's San Diego (Del Mar) office. He is Co-Team Leader of the firm's Technology Transactions Team, and a member of the Life Sciences and Digital Health teams. He founded a software-as-a-service (SaaS) business prior to attending law school, and worked at a publicly-traded biotechnology company on an in-house secondment, and uses that experience in bringing a practical, business-oriented approach to his engagements.

    For over 20 years, Michael has been assisting innovators, cutting-edge technology companies and other organizations develop, acquire, sell, and commercialize intellectual property assets, including technology licensing, commercial agreements, strategic partnerships, research, development and collaboration contracts, manufacturing and supply arrangements, outsourcing, and corporate transactions.

    Contact Information

    Ron Skillens

    Michael Orlando

    Additional Resources

    AI Governance Checklist

    Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month.

    If you enjoyed this episode, please help us get the word out about this podcast. Rate and

    Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show.

    This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    Show More Show Less
    17 mins
  • Crossroads of Care: Navigating Executive Orders with Jonathan Meyer, former DHS GC and Partner at Sheppard Mullin

    Crossroads of Care: Navigating Executive Orders with Jonathan Meyer, former DHS GC and Partner at Sheppard Mullin
    Feb 25 2025
    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Jonathan Meyer, a partner at Sheppard Mullin and Leader of the firm's National Security Team, joins us again to discuss the early days of the new Trump administration and what might be on the horizon in terms of cybersecurity and data privacy. What We Discussed in This Episode: What can we expect from the new administration in relation to cybersecurity and data protection? How do these concerns translate to healthcare, both in terms of managing our care and protecting our data? What is Sheppard Mullin's executive actions tracker, why it matters, and how can listeners use it? How is healthcare struggling with privacy and immigration, and how does this impact national security? About Jonathan Meyer As a partner in Sheppard Mullin's Governmental Practice Group and leader of the firm's National Security team, Jonathan E. Meyer counsels clients on their interactions with federal and state government, as well as national and homeland security, Congressional oversight, cybersecurity, AI, high tech, and transportation security, among other issues. Prior to returning to Sheppard Mullin, Jon was nominated by President Biden and confirmed by the Senate as the Sixth General Counsel of the U.S. Department of Homeland Security, serving from 2021 to 2024. His decades of experience in Congress, the Justice Department and DHS position him to bring an insider's perspective to interactions between private companies and the government. He has defended scores of Congressional investigations and has prepared witnesses for over 100 hearings, including Supreme Court nomination hearings, impeachment hearings, oversight hearings, high tech and antitrust investigations, and civil rights investigations, among others. He has also represented defendants and witnesses in high-stakes Justice Department criminal investigations. The media – including CBS News, NPR, The Wall Street Journal, The New York Times, The Washington Post and Politico – regularly turn to Jon for insight into issues regarding national security, homeland security, government investigations, cybersecurity, immigration, politics and Congress. He has twice been honored with the Secretary of Homeland Security's Outstanding Service Medal, the highest civilian award bestowed by DHS. He has also received the U.S. Secret Service Director's Honor Award, the Customs and Border Protection Commissioner's Ensign Award, and the U.S. Coast Guard Commandant's Distinguished Service Medal, among numerous other prestigious accolades recognizing his exceptional service. About Sara Shanti A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti's practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care. Contact Information Jonathan E. Meyer Sara Shanti Additional Resources Trump Executives Action Tracker Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    Show More Show Less
    9 mins
  • Healthcare Security is Homeland Security with Jonathan Meyer, former DHS GC and Partner at Sheppard Mullin

    Healthcare Security is Homeland Security with Jonathan Meyer, former DHS GC and Partner at Sheppard Mullin
    Feb 5 2025
    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Jonathan Meyer, former general counsel of the Department of Homeland Security and Leader of Sheppard Mullin's National Security Team, joins us to discuss cyberthreats and data security from the perspective of national security, including the implications for healthcare. What We Discussed In This Episode How do cyberattacks and data privacy impact national security? How can personal data be weaponized to cause harm to an individual, and why should people care? Many adults are aware they need to keep their own personal data secure for financial reasons, but what about those who aren't financially active, such as children? How is healthcare particularly vulnerable to cyberthreats, even outside the hospital setting? What can stakeholders do better at the healthcare level? What can individuals do better to ensure their personal data remains secure? About Jonathan Meyer As a partner in Sheppard Mullin's Governmental Practice Group and leader of the firm's National Security team, Jonathan E. Meyer counsels clients on their interactions with federal and state government, as well as national and homeland security, Congressional oversight, cybersecurity, AI, high tech, and transportation security, among other issues. Prior to returning to Sheppard Mullin, Jon was nominated by President Biden and confirmed by the Senate as the Sixth General Counsel of the U.S. Department of Homeland Security, serving from 2021 to 2024. His decades of experience in Congress, the Justice Department and DHS position him to bring an insider's perspective to interactions between private companies and the government. He has defended scores of Congressional investigations and has prepared witnesses for over 100 hearings, including Supreme Court nomination hearings, impeachment hearings, oversight hearings, high tech and antitrust investigations, and civil rights investigations, among others. He has also represented defendants and witnesses in high-stakes Justice Department criminal investigations. The media – including CBS News, NPR, The Wall Street Journal, The New York Times, The Washington Post and Politico – regularly turn to Jon for insight into issues regarding national security, homeland security, government investigations, cybersecurity, immigration, politics and Congress. He has twice been honored with the Secretary of Homeland Security's Outstanding Service Medal, the highest civilian award bestowed by DHS. He has also received the U.S. Secret Service Director's Honor Award, the Customs and Border Protection Commissioner's Ensign Award, and the U.S. Coast Guard Commandant's Distinguished Service Medal, among numerous other prestigious accolades recognizing his exceptional service. About Sara Shanti A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti's practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care. Contact Information Jonathan E. Meyer Sara Shanti Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    Show More Show Less
    13 mins